Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stockguard Animal Health is a New Zealand-based veterinary pharmaceutical company that specializes in health solutions for the livestock industry. The company is primarily recognized for its development and commercialization of vaccines and parasiticides tailored for cattle and sheep. Its core product portfolio includes vaccines for neonatal calf diarrhea (scours) and bovine viral diarrhea (BVD), alongside a range of anthelmintic drenches. In 2011, Stockguard was acquired by Dechra Pharmaceuticals, a global leader in specialist veterinary medicines. Since the acquisition, Stockguard's products have been integrated into Dechra's broader animal health offering, continuing to serve the agricultural sector in the Oceania region. The company's expertise in preventative medicine has made it a key contributor to livestock productivity and welfare in its target markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stockguard Animal Health.